Gsk (GSK) EBITDA (2009 - 2026)
Gsk's EBITDA came in at $4.09 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported EBITDA of $9.59 billion; for the year ended Dec 31, 2025, it was $15.44 billion, up 72.4% from the prior year.
- EBITDA carries a five-year compound annual growth rate of 19.1% (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA was $8.96 billion in the year ended Dec 31, 2024 (-25.0%), $11.93 billion in the year ended Dec 31, 2023 (+24.1%), $9.61 billion in the year ended Dec 31, 2022 (+28.3%) and $7.49 billion in the year ended Dec 31, 2021 (+16.5%).
- The figure for the quarter ended Sep 8, 2026 represents the highest quarterly EBITDA since the quarter ended Dec 31, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Bn |
| Dec 31, 2025 | -2.04 Bn |
| Mar 31, 2025 | 3.83 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Mar 31, 2024 | 2.59 Bn |
| Dec 31, 2023 | 2.17 Bn |
| Mar 31, 2023 | 3.31 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Mar 31, 2022 | 3.64 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Mar 31, 2021 | 2.17 Bn |
| Dec 31, 2020 | 278.62 Mn |
| Mar 31, 2020 | 2.83 Bn |
| Dec 31, 2019 | 3.12 Bn |
| Sep 30, 2019 | 3.28 Bn |
| Mar 31, 2019 | 3.40 Bn |
| Dec 31, 2018 | 2.76 Bn |
| Mar 31, 2018 | 2.39 Bn |
| Dec 31, 2017 | 1.85 Bn |
| Mar 31, 2017 | 2.53 Bn |
API Access
Gsk EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();